Brief: Infinity Pharmaceuticals Announces Stockholder Approval Of Merger With Mei Pharma
14/07/2023 19:27
July 14 (Reuters) - Infinity Pharmaceuticals Inc
INFI.O :
* INFINITY PHARMACEUTICALS ANNOUNCES STOCKHOLDER APPROVAL OF
MERGER WITH MEI PHARMA
Source text for Eikon: ID:nBw2qbT11a
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations